Intuitive Surgical, Inc. (ISRG)
| Market Cap | 201.13B |
| Revenue (ttm) | 9.61B |
| Net Income (ttm) | 2.75B |
| Shares Out | 354.50M |
| EPS (ttm) | 7.56 |
| PE Ratio | 75.07 |
| Forward PE | 61.30 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,206,205 |
| Open | 568.99 |
| Previous Close | 573.48 |
| Day's Range | 566.63 - 573.54 |
| 52-Week Range | 425.00 - 616.00 |
| Beta | 1.69 |
| Analysts | Buy |
| Price Target | 595.47 (+4.95%) |
| Earnings Date | Oct 21, 2025 |
About ISRG
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling,... [Read more]
Financial Performance
In 2024, Intuitive Surgical's revenue was $8.35 billion, an increase of 17.24% compared to the previous year's $7.12 billion. Earnings were $2.32 billion, an increase of 29.18%.
Financial StatementsAnalyst Summary
According to 15 analysts, the average rating for ISRG stock is "Buy." The 12-month stock price target is $595.47, which is an increase of 4.95% from the latest price.
News
Is Intuitive Surgical's Dominance Safe? 10 Years of Healthcare Upside
Intuitive Surgical has long led the robotic-assisted surgery market. The company will soon see significantly more competition in the field.
Can Intuitive Surgical Still Be A Good Buy?
Intuitive Surgical (ISRG) stock may be a solid investment at this time. Why? Because you're getting high margins – indicative of pricing power and cash generation capability – for a discounted price.
What Are the Best Healthcare Stocks to Buy Now? I Think It's Intuitive Surgical (ISRG) -- or, to Play It Safer, Medtronic (MDT)
Intuitive Surgical is the 800-pound gorilla in the robotic surgery space. Medtronic is entering the field and pays a solid dividend, too.
2 Healthcare Stocks for Beginner Investors With a 10-Year Time Horizon
These top healthcare stocks are raking in profits and have compelling growth stories. Intuitive Surgical is the leader in the surgical robotics market.
Where Will Intuitive Surgical Stock Be in 10 Years?
Intuitive Surgical is selling an increasing number of da Vinci surgical robots. The number of procedures performed with a da Vinci robot is rising rapidly.
PGIM Jennison Health Sciences Fund Q3 2025 Contributors And Detractors
The S&P 1500 Health Care Index advanced 4.0% in the third quarter, underperforming the S&P 500, which gained 8.1%. Stock selection within biotechnology and health care providers & services, along with...
Robotic Surgery Will Explode: Buy This Healthcare Stock Before Its 50% Run.
Intuitive Surgical is a pioneer in the field of surgical robotics. The company's da Vinci system is a leading technology platform in its segment.
9 Robotics Stocks to Buy Before the Automation Wave Peaks
Aging populations and wage inflation are making automation economically compelling across warehouses, factories, hospitals, and service industries. The robotics market encompasses a range of industrie...
Baron Fifth Avenue Growth Fund Q3 2025 Performance Update
Baron Fifth Avenue Growth Fund gained 5.7% during the third quarter, lagging the 10.5% gain for the Russell 1000 Growth Index and the 8.1% gain for the S&P 500 Index, the Fund's benchmarks. NVIDIA rep...
Is It Time to Dump Your Shares of Intuitive Surgical?
Intuitive Surgical makes da Vinci surgical robots used around the globe. The company has seen tremendous growth and is still growing quickly.
2 Healthcare Stocks for Beginner Investors With a 40-Year Time Horizon
These companies are leaders in their respective industries and are both very profitable. Intuitive Surgical has been the dominant presence in the surgical robotics market for decades.
The Motley Fool Analysts Andy Cross, Emily Flippen, and Jason Moser on How Tariffs Are Impacting Intuitive Surgical's Profits Right Now
Intuitive Surgical reduced its projected tariff impact on gross margins by 30 basis points this quarter. The medical device leader's ability to navigate tariff uncertainty while raising guidance acros...
RiverPark Long/Short Opportunity Fund: Q3 2025 Top And Bottom Performers
GOOG was our top contributor in the quarter, benefiting from accelerating momentum in its core Search and YouTube franchises. We continue to view Alphabet as among the best-positioned secular growth f...
PODD Vs. Intuitive Surgical: This Underdog Might Just Win
When it comes to surgical innovation, Intuitive Surgical (NASDAQ: ISRG) often dominates investor attention. But Insulet Corporation (NASDAQ: PODD), best known for its Omnipod insulin delivery system, ...
Izzy Englander and Cathie Wood Agree: This Growth Stock Is a Buy
Intuitive Surgical features in Ark Invest and Millennium Management's portfolios. The company is facing issues: mounting competition, tariffs, and a steep valuation.
Intuitive Surgical Is the Robotic-Assisted Surgery Leader, but Medtronic Is Making Moves. Here's What Investors Need to Know.
Intuitive Surgical's da Vinci surgical robot is an industry leader in one specific area. Medtronic offers both a surgical robot and a more diverse business beyond it.
Intuitive Surgical Stock To $700?
Intuitive Surgical (ISRG) has been on a powerful run, fueled by rising adoption of its da Vinci robotic systems and steady growth in surgical procedure volumes worldwide. The stock has outpaced both t...
How Intuitive Surgical Stock Gained 19.5% Last Month
Intuitive Surgical's third-quarter earnings beat expectations with 23% sales growth, and earnings of $2.40 per share versus $1.99 expected. The stock trades at 72 times earnings, which sounds expensiv...
2 Healthcare Stocks for Individual Investors With a 30-Year Time Horizon
Healthcare stocks can provide growth and consistent returns through a variety of market cycles. Eli Lilly has a storied history as a company, and the GLP-1 boom is just the latest phase in its growth ...
Prediction: These 2 Magnificent S&P 500 Growth Stocks Will Crush the Market Over the Next 5 Years
Intuitive Surgical can deal with headwinds and deliver more blowout quarterly updates. Visa's vast financial business can deal with challenges that may be coming our way.
Abner Herrman & Brock Sours on Intuitive Surgical
Abner Herrman & Brock sold 9,629 shares of Intuitive Surgical, worth around $4.62 million. Intuitive Surgical now represents 1% of AHB's AUM, placing it outside the fund's top five holdings As of Sept...
3 Robotics Stocks to Buy Right Now
The U.S. public robotics space grew 60% from mid-2024 to mid-2025, outpacing broader tech indexes as the sector matures. Defense robotics spending surged 150% from 2024 to 2025, jumping from $3.3 bill...
Masso Torrence Wealth Management Liquidates $2.7 Million Intuitive Surgical (NASDAQ: ISRG) Stake: Is the Stock a Sell?
Masso Torrence Wealth Management sold 4,979 shares of Intuitive Surgical; estimated trade value of approximately $2.71 million. Post-trade stake in ISRG is zero shares, valued at $0.
Baron Health Care Fund Q3 2025 Top Contributors And Detractors
Argenx SE is a biotechnology company best known for developing Vyvgart, the leading FcRn inhibitor for the treatment of autoimmune conditions. RadNet, Inc. is the largest operator of outpatient diagno...
3 Healthcare Stocks to Buy Hand Over Fist in October
Intuitive Surgical just put up a strong quarter, reminding Wall Street that it is a growth stock. Merck is a drug giant with a yield near the highest levels of the past decade and a reasonable payout ...